The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The FDA recalled 60 doughnut products, totaling more than 2 million cases, for potential listeria contamination. The ...
Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...
The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...
According to the FDA, If consumers have an allergy or sensitivity to milk, they should not consume the product and discard it ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The recall, which impacts approximately 2 million baked goods, was issued for products manufactured by FGF Brands over ...
3d
Martha Stewart Living on MSNChocolate Recall Considered Class I Due to 'Deadly' Allergen Risk, FDA WarnsIn December, the United States Food and Drug Administration (FDA) announced a recall on various chocolate products ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...
The Associated Press on MSN9d
FDA approves first new class of painkiller in 20 years, a non-addictive opioid alternativeThe medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results